Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma

Stopped The protocol was amendment to be stopped after phase I (phase 2 removed from protocol)

Conditions

• Adult Glioblastoma

Interventions

• OTHER: Laboratory Biomarker Analysis
• BIOLOGICAL: Pembrolizumab
• RADIATION: Radiation Therapy
• DRUG: Temozolomide

Sponsor

Northwestern University

Collaborators

• [object Object]
• [object Object]